Hans Lilja
231 – 240 of 460
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Cutpoints in clinical chemistry : Time for fundamental reassessment
(
- Contribution to journal › Article
-
Mark
In reply
(
- Contribution to journal › Letter
-
Mark
Evaluation of molecular forms of prostate-specific antigen and human kallikrein 2 in predicting biochemical failure after radical prostatectomy
(
- Contribution to journal › Article
- 2008
-
Mark
A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden
(
- Contribution to journal › Article
-
Mark
Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: A case-control study
(
- Contribution to journal › Article
-
Mark
The role of SPINK1 in ETS rearrangement-negative prostate cancers
(
- Contribution to journal › Article
-
Mark
Prostate-specific antigen and prostate cancer: prediction, detection and monitoring
(
- Contribution to journal › Scientific review
-
Mark
Long-term prediction of prostate cancer: Prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened population
(
- Contribution to journal › Article
-
Mark
Beta-microseminoprotein in serum correlates with the levels in seminal plasma of young, healthy males
(
- Contribution to journal › Article
-
Mark
Total prostate specific antigen stability confirmed after long-term storage of serum at -80C - Comment
(
- Contribution to journal › Debate/Note/Editorial